Roche, Illumina, and ABI Use HUGO Meeting to Showcase New Next-Gen Apps, Enhancements | GenomeWeb
MONTREAL - Roche, Illumina, and Applied Biosystems presented updates on applications for and projects involving their respective next-gen sequencing platforms at last week’s HGM 2007 Human Genome Meeting in Montreal.
 
Illumina and ABI also spoke about how their instruments will likely perform in the near future (see table, below).
 
Roche
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.